Related Experiment Video
Updated: Sep 29, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Identifying poor responders to repetitive transcranial magnetic stimulation using structural brain networks
1Department of Neurology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China; Department of Radiology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
Background:
The efficacy of repetitive transcranial magnetic stimulation (rTMS) for depression varies widely. We examined whether pretreatment structural brain networks, specifically rich-club connection strength (RCS) and modularity, were associated with this variability and could help predict therapeutic outcomes.
Methods:
In a prospective cohort of 204 depressed patients receiving 4-week left prefrontal rTMS, baseline diffusion MRI was used to quantify structural network rich-club organization and modularity. We assessed their associations with clinical outcomes (improvement, response, remission) and compared the predictive accuracy of clinical, network, and combined models.
Results:
Patients with non-response and non-remission showed significantly lower baseline RCS and modularity than their respective comparison groups (all P < 0.05). Patients with concurrent reductions in both measures (low RCS/low modularity group) had the lowest response and remission rates among the four network groups (both P < 0.05), and this group was independently associated with non-response and non-remission in adjusted logistic models (both P < 0.05). The combined clinical-imaging model showed better discrimination than the clinical model alone for both response and remission. In the repeated-scan subsample, the low RCS/low modularity group showed less treatment-related network reorganization.
Conclusions:
Lower baseline RCS and modularity were associated with poorer antidepressant outcome after rTMS in depression. Their combination identified a subgroup with particularly poor clinical improvement and limited network reorganization, suggesting that network-based markers may have prognostic value.
